Detalhe da pesquisa
1.
Validation and comparison of 5th edition World Health Organization classification (WHO 2022) and International Consensus Classification proposals for MDS-SFB31.
Br J Haematol
; 2024 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38654443
2.
Impact of the International Consensus Classification of myelodysplastic syndromes.
Br J Haematol
; 201(3): 443-448, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36575970
3.
ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.
Haematologica
; 108(5): 1359-1373, 2023 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36005555
4.
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Hematol Oncol
; 40(4): 787-795, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35609279
5.
Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations.
Br J Haematol
; 192(6): 1006-1010, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32307695
6.
Is race important in genomic classification of hematological neoplasms?
Hematol Oncol
; 39(5): 728-732, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34392561
7.
Evaluation of Reduced-Dose Decitabine and Azacitidine for Treating Myelodysplastic Syndromes: A Retrospective Study.
Med Sci Monit
; 27: e928454, 2021 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33514682
8.
Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes.
Genes Chromosomes Cancer
; 57(2): 80-88, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29057546
9.
Distinguishing myelodysplastic syndromes with moderate-to-severe bone marrow fibrosis from triple-negative primary myelofibrosis based on clinical and genetic covariates.
Hematol Oncol
; 41(3): 598-602, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36265165
10.
Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center.
Haematologica
; 107(4): 991-995, 2022 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34989218
11.
Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia.
Br J Haematol
; 188(5): 796-800, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31880320
12.
Prognostic impact of red blood cell distribution width in myelodysplastic syndromes.
Br J Haematol
; 186(2): 352-355, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30836422
13.
Unique features of primary myelofibrosis in Chinese.
Blood
; 119(11): 2469-73, 2012 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22262778
14.
Cytogenetic studies and their prognostic contribution in 565 Chinese patients with primary myelofibrosis.
Am J Hematol
; 89(11): 1043-6, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-25132428
15.
Monosomal karyotype is an independent predictor of survival in patients with higher-risk myelodysplastic syndrome.
Am J Hematol
; 89(10): E163-8, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25044281
16.
Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutations.
Hematology
; 29(1): 2338509, 2024 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38597818
17.
Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis.
Leukemia
; 2024 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-38714876
18.
The usefulness of mutational data on prognosis of myelodysplastic syndromes: alone or incorporated into the IPSS-R?
Br J Haematol
; 183(5): 815-819, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29193004
19.
Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy.
Leuk Res Rep
; 19: 100367, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36968263
20.
Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteins.
Blood Sci
; 5(4): 258-268, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37941916